De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
KalVista Pharmaceuticals Eigendom
Wie zijn de grootste aandeelhouders en hebben insiders gekocht of verkocht?
Recente transacties met voorkennis
Datum | Waarde | Naam | Entiteit | Rol | Aandelen | Maximale prijs |
---|---|---|---|---|---|---|
28 Mar 24 | SellUS$14,905,154 | TCG Crossover Management, LLC | Company | 1,355,014 | US$11.00 | |
20 Feb 24 | BuyUS$999,988 | Frazier Life Sciences Management, LP | Company | 65,573 | US$15.25 | |
16 Feb 24 | SellUS$13,151,726 | TCG Crossover Management, LLC | Company | 877,125 | US$16.22 | |
14 Feb 24 | SellUS$598,661 | Christopher Yea | Individual | 39,886 | US$15.01 | |
14 Feb 24 | SellUS$422,827 | Edward Feener | Individual | 28,171 | US$15.01 | |
14 Feb 24 | SellUS$875,883 | Thomas Crockett | Individual | 58,356 | US$15.01 | |
14 Feb 24 | SellUS$613,205 | Benjamin Palleiko | Individual | 40,855 | US$15.01 | |
08 Feb 24 | BuyUS$1,257,829 | VR Adviser, LLC | Company | 86,048 | US$14.74 | |
30 Jan 24 | BuyUS$1,274,793 | VR Adviser, LLC | Company | 88,099 | US$14.47 | |
25 Jan 24 | BuyUS$89,492 | VR Adviser, LLC | Company | 7,030 | US$12.73 | |
24 Jan 24 | BuyUS$1,241,685 | VR Adviser, LLC | Company | 99,129 | US$12.55 | |
19 Jan 24 | BuyUS$1,801,602 | VR Adviser, LLC | Company | 143,605 | US$12.60 | |
16 Jan 24 | BuyUS$333,779 | VR Adviser, LLC | Company | 26,246 | US$12.73 | |
10 Jan 24 | BuyUS$1,726,457 | VR Adviser, LLC | Company | 137,700 | US$12.67 | |
04 Jan 24 | BuyUS$720,543 | VR Adviser, LLC | Company | 59,369 | US$12.20 | |
29 Dec 23 | BuyUS$6,465,650 | VR Adviser, LLC | Company | 519,017 | US$12.50 | |
12 Dec 23 | BuyUS$2,972,278 | Frazier Life Sciences Management, LP | Company | 343,435 | US$9.53 |
Volume handel met voorkennis
Insider-aankopen: Er zijn onvoldoende gegevens om te bepalen of insiders de afgelopen 3 maanden meer aandelen hebben gekocht dan verkocht.
Opsplitsing eigendom
Type eigenaar | Aantal Aandelen | Eigendomspercentage |
---|---|---|
Individuele insiders | 704.282 | 1,44% |
Hedgefondsen | 6.492.005 | 13,2% |
VC/PE-bedrijven | 9.937.598 | 20,2% |
Instellingen | 31.944.662 | 65,1% |
Verwatering van aandelen: De aandeelhouders zijn het afgelopen jaar verwaterd, waarbij het totale aantal uitstaande aandelen met 25.6% is gegroeid.
Topaandeelhouders
Eigendom | Naam | Aandelen | Huidige waarde | Verandering % | Portefeuille % | |
---|---|---|---|---|---|---|
6.249.731 | US$74.0m | 0% | 2,89% | |||
4.218.829 | US$50.0m | 2,27% | 4,16% | |||
4.192.005 | US$49.6m | 0% | 1,8% | |||
3.687.867 | US$43.7m | 0% | 1,74% | |||
3.227.620 | US$38.2m | 120% | geen gegevens | |||
2.945.116 | US$34.9m | 21,1% | geen gegevens | |||
2.300.000 | US$27.2m | 251% | 1,78% | |||
2.050.000 | US$24.3m | -20,4% | 0,04% | |||
1.990.588 | US$23.6m | 18,1% | geen gegevens | |||
1.590.000 | US$18.8m | 0% | 0,9% | |||
1.338.568 | US$15.8m | 0% | 2,9% | |||
1.173.262 | US$13.9m | -2,27% | 0,3% | |||
1.128.478 | US$13.4m | -21,7% | 4,51% | |||
1.059.540 | US$12.5m | -10,2% | 1,88% | |||
881.937 | US$10.4m | 15,9% | 1,59% | |||
806.973 | US$9.6m | 0% | 2,17% | |||
806.271 | US$9.5m | 23,7% | geen gegevens | |||
756.430 | US$9.0m | 27,3% | geen gegevens | |||
736.765 | US$8.7m | -36,5% | 2,36% | |||
560.883 | US$6.6m | -0,05% | 1,57% | |||
535.717 | US$6.3m | -1,07% | 0,04% | |||
534.979 | US$6.3m | -7,71% | geen gegevens | |||
500.000 | US$5.9m | 0% | 0,13% | |||
467.998 | US$5.5m | 83,7% | geen gegevens | |||
337.985 | US$4.0m | 17,4% | 2,64% |